Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
2
pubmed:dateCreated
2001-5-30
pubmed:abstractText
Fifteen cases of endometrial cancer were administered daily doses of 600 mg of MPA after surgery to prevent the recurrence of cancer. The initiation times of coagulation (time necessary for fibrin network formation) were measured with a highly sensitive damped oscillation rheometer and compared with those of 15 control patients who were not administered MPA. Biochemical studies of blood coagulation and fibrinolysis were also done. The initiation times of coagulation were 19.0+/-1.8 minutes (min mean +/- standard deviation) after 3-6 months and 16.0+/-2.0 min after 9-12 months of MPA administration, both times being significantly shorter compared with the controls (24.0+/-2.5 min). Hematocrit values, platelet counts and fibrinogen levels were similar between the two groups. Activated partial thromboplastin time (APTT) was significantly decreased and antithrombin III activity (AT III), thrombin-antithrombin complex (TAT), plasminogen level, plasmin-alpha(2) plasmin inhibitor complex level (PIC) and the fibrin degradation product level (FDP) were significantly increased in the MPA group compared with the control group. Accelerated coagulation of blood was definitely induced by high-dose MPA but antithrombin and fibrinolytic activities were also induced, and, thus, thromboembolic complications were prevented.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Antifibrinolytic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, Hormonal, http://linkedlifedata.com/resource/pubmed/chemical/Antithrombin III, http://linkedlifedata.com/resource/pubmed/chemical/Fibrin Fibrinogen Degradation..., http://linkedlifedata.com/resource/pubmed/chemical/Fibrinogen, http://linkedlifedata.com/resource/pubmed/chemical/Fibrinolysin, http://linkedlifedata.com/resource/pubmed/chemical/Medroxyprogesterone Acetate, http://linkedlifedata.com/resource/pubmed/chemical/Peptide Hydrolases, http://linkedlifedata.com/resource/pubmed/chemical/alpha-2-Antiplasmin, http://linkedlifedata.com/resource/pubmed/chemical/antithrombin III-protease complex, http://linkedlifedata.com/resource/pubmed/chemical/plasmin-plasmin inhibitor complex
pubmed:status
MEDLINE
pubmed:issn
1386-0291
pubmed:author
pubmed:issnType
Print
pubmed:volume
24
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
93-9
pubmed:dateRevised
2009-11-19
pubmed:meshHeading
pubmed-meshheading:11381184-Adult, pubmed-meshheading:11381184-Aged, pubmed-meshheading:11381184-Antifibrinolytic Agents, pubmed-meshheading:11381184-Antineoplastic Agents, Hormonal, pubmed-meshheading:11381184-Antithrombin III, pubmed-meshheading:11381184-Blood Coagulation, pubmed-meshheading:11381184-Blood Coagulation Tests, pubmed-meshheading:11381184-Blood Viscosity, pubmed-meshheading:11381184-Combined Modality Therapy, pubmed-meshheading:11381184-Endometrial Neoplasms, pubmed-meshheading:11381184-Female, pubmed-meshheading:11381184-Fibrin Fibrinogen Degradation Products, pubmed-meshheading:11381184-Fibrinogen, pubmed-meshheading:11381184-Fibrinolysin, pubmed-meshheading:11381184-Fibrinolysis, pubmed-meshheading:11381184-Hematocrit, pubmed-meshheading:11381184-Hemostasis, pubmed-meshheading:11381184-Humans, pubmed-meshheading:11381184-Hysterectomy, pubmed-meshheading:11381184-Medroxyprogesterone Acetate, pubmed-meshheading:11381184-Middle Aged, pubmed-meshheading:11381184-Partial Thromboplastin Time, pubmed-meshheading:11381184-Peptide Hydrolases, pubmed-meshheading:11381184-Platelet Count, pubmed-meshheading:11381184-Risk, pubmed-meshheading:11381184-Thrombophilia, pubmed-meshheading:11381184-alpha-2-Antiplasmin
pubmed:year
2001
pubmed:articleTitle
Effect of high-dose progestogen on hemostatic properties of blood in patients with endometrial cancer.
pubmed:affiliation
Department of Obstetrics and Gynecology, Ichihara Hospital, School of Medicine, Teikyo University, Ichihara City, Chiba, Japan.
pubmed:publicationType
Journal Article